Cite
HARVARD Citation
Comella, C. et al. (n.d.). A phase 2, open-label, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxina for injection (RT002) in isolated cervical dystonia. Toxicon. pp. S18-. [Online].